Literature DB >> 7102850

Telephone versus in-person surveys of community health status.

C S Aneshensel, R R Frerichs, V A Clark, P A Yokopenic.   

Abstract

Reports of physical morbidity are compared among a community sample of Los Angeles County adults (N = 546) randomly assigned to either in-person or telephone interviews. No statistically significant differences were found between the two interview methods for overall assessment of health status, illnesses reported for the previous four months, or reports of hospitalization. A significantly greater proportion of in-person respondents, however, reported the presence of restricted-activity days during the previous two weeks. This difference could not be directly attributed to sociodemographic characteristics or reported physical health status of the two samples.

Entities:  

Mesh:

Year:  1982        PMID: 7102850      PMCID: PMC1650092          DOI: 10.2105/ajph.72.9.1017

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  4 in total

1.  Medical economics survey-methods study: cost-effectiveness of alternative survey strategies.

Authors:  R Yaffe; S Shapiro; R R Fuchseberg; C A Rohde; H C Corpeno
Journal:  Med Care       Date:  1978-08       Impact factor: 2.983

2.  Personal versus telephone interviews: effect on responses.

Authors:  J Colombotos
Journal:  Public Health Rep       Date:  1969-09       Impact factor: 2.792

3.  A comparison of mail, telephone, and home interview strategies for household health surveys.

Authors:  J Siemiatycki
Journal:  Am J Public Health       Date:  1979-03       Impact factor: 9.308

4.  Measuring depression in the community: a comparison of telephone and personal interviews.

Authors:  C S Aneshensel; R R Frerichs; V A Clark; P A Yokopenic
Journal:  Public Opin Q       Date:  1982
  4 in total
  13 in total

1.  Policy makers' perspectives on tobacco control advocates' roles in regulation development.

Authors:  T Montini; L A Bero
Journal:  Tob Control       Date:  2001-09       Impact factor: 7.552

2.  Prevalence of spondyloarthropathies in France: 2001.

Authors:  A Saraux; F Guillemin; P Guggenbuhl; C H Roux; P Fardellone; E Le Bihan; A Cantagrel; I Chary-Valckenaere; L Euller-Ziegler; R-M Flipo; R Juvin; J-M Behier; B Fautrel; C Masson; J Coste
Journal:  Ann Rheum Dis       Date:  2005-04-07       Impact factor: 19.103

3.  Sleep Patterns in Children with Cystic Fibrosis.

Authors:  Lisa J Meltzer; Suzanne E Beck
Journal:  Child Health Care       Date:  2012

4.  Personal versus telephone surveys for collecting household health data at the local level.

Authors:  M F Weeks; R A Kulka; J T Lessler; R W Whitmore
Journal:  Am J Public Health       Date:  1983-12       Impact factor: 9.308

5.  Statewide survey of risk factor prevalence: the Ohio experience.

Authors:  M S Chen; D Bill
Journal:  Public Health Rep       Date:  1983 Sep-Oct       Impact factor: 2.792

6.  Non-participation in telephone follow-up interviews.

Authors:  A C Marcus; C W Telesky
Journal:  Am J Public Health       Date:  1983-01       Impact factor: 9.308

7.  Medical versus nonmedical mental health referral: clinical decision-making by telephone access center staff.

Authors:  Myron L Pulier; Donald S Ciccone; Cherie Castellano; Karen Marcus; Steven J Schleifer
Journal:  J Behav Health Serv Res       Date:  2003 Oct-Dec       Impact factor: 1.505

8.  Autonomy, positive relationships, and IL-6: evidence for gender-specific effects.

Authors:  Tory Eisenlohr-Moul; Suzanne Segerstrom
Journal:  Br J Health Psychol       Date:  2012-08-22

9.  Prevalence and comorbidity of psychiatric diagnoses based on reference standard in an HIV+ patient population.

Authors:  Bradley N Gaynes; Brian Wells Pence; Joseph J Eron; William C Miller
Journal:  Psychosom Med       Date:  2008-03-31       Impact factor: 4.312

10.  Evaluation of birth defect histories obtained through maternal interviews.

Authors:  S A Rasmussen; J Mulinare; M J Khoury; E K Maloney
Journal:  Am J Hum Genet       Date:  1990-03       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.